Kidney cancer in 2010: Drugs, surgery and survival in RCC

Nature Reviews Urology

Volumn 8, Issue 2, 2011, Pages 66-68

  Bensalah, Karim ^a   Patard, Jean Jacques ^b  

^a RENNES UNIVERSITY HOSPITAL   (France)

^b BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; EVEROLIMUS; PAZOPANIB; PLACEBO; SORAFENIB; SUNITINIB; TEMSIROLIMUS;

ACUTE KIDNEY FAILURE; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; COLD ISCHEMIA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ELDERLY CARE; HUMAN; ISCHEMIA; KIDNEY CARCINOMA; KIDNEY FUNCTION; MEDICAL DECISION MAKING; NEPHRON SPARING SURGERY; NOMOGRAM; PARTIAL NEPHRECTOMY; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT RESPONSE; TUMOR RECURRENCE; TUMOR VOLUME; UNSPECIFIED SIDE EFFECT;

ANIMALS; CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; PHARMACEUTICAL PREPARATIONS; SURVIVAL RATE;

EID: 79951479067     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2010.228     Document Type: Review

References (8)

1. Bensalah, K., Crépel, M. & Patard, J. J. Tumor size and nephron-sparing surgery: does it still matter? Eur. Urol. 53, 691-693 (2008). (Pubitemid 351273887)
2. Weight, C. J. et al. Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. J. Urol. 183, 1317-1323 (2010).
3. Thompson, R. H. et al. Every minute counts when the renal hilum is clamped during partial nephrectomy. Eur. Urol. 58, 340-345 (2010).
4. Bensalah, K. et al. Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery. Eur. Urol. 57, 466-471 (2010).
5. Yossepowitch, O. et al. Positive surgical margins at partial nephrectomy: predictors and oncological outcomes. J. Urol. 179, 2158-2163 (2008).
6. Sternberg, C. N. et al. Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase iii trial. J. Clin. Oncol. 28, 1061-1068 (2010).
7. Chawla, S. N. et al. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J. Urol. 175, 425-431 (2006). (Pubitemid 43067318)
8. Kutikov, A., Egleston, B. L., Wong, Y. N. & Uzzo, R. G. Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram. J. Clin. Oncol. 28, 311-317 (2010).